Strs Ohio Takes Position in Teladoc Health, Inc. $TDOC

Strs Ohio acquired a new position in Teladoc Health, Inc. (NYSE:TDOC) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 43,900 shares of the health services provider’s stock, valued at approximately $349,000.

Other hedge funds have also recently bought and sold shares of the company. Golden State Wealth Management LLC lifted its stake in shares of Teladoc Health by 102.6% during the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider’s stock valued at $27,000 after acquiring an additional 1,690 shares during the period. National Bank of Canada FI raised its holdings in Teladoc Health by 79.4% during the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider’s stock worth $28,000 after purchasing an additional 1,581 shares during the last quarter. SVB Wealth LLC acquired a new position in Teladoc Health during the 1st quarter valued at about $37,000. BI Asset Management Fondsmaeglerselskab A S bought a new position in shares of Teladoc Health in the 1st quarter valued at about $50,000. Finally, Brucke Financial Inc. acquired a new stake in shares of Teladoc Health during the 4th quarter worth approximately $92,000. 76.82% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. Truist Financial reduced their price objective on shares of Teladoc Health from $10.00 to $9.00 and set a “hold” rating on the stock in a research note on Tuesday, May 27th. Mizuho initiated coverage on Teladoc Health in a research report on Friday, July 25th. They issued a “neutral” rating and a $10.00 price target on the stock. Evercore ISI upped their price objective on Teladoc Health from $7.00 to $8.00 and gave the company an “in-line” rating in a report on Wednesday, July 9th. Finally, Bank of America reduced their target price on Teladoc Health from $8.00 to $7.00 and set a “neutral” rating on the stock in a report on Wednesday, May 28th. Six research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $9.80.

Teladoc Health Stock Up 2.4%

Teladoc Health stock opened at $8.39 on Wednesday. The company has a 50 day moving average of $7.66 and a 200-day moving average of $7.62. The company has a quick ratio of 2.58, a current ratio of 2.67 and a debt-to-equity ratio of 0.70. Teladoc Health, Inc. has a twelve month low of $6.35 and a twelve month high of $15.21. The stock has a market capitalization of $1.48 billion, a PE ratio of -7.05 and a beta of 1.84.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.08. The business had revenue of $631.90 million for the quarter, compared to analysts’ expectations of $621.91 million. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The firm’s revenue was down 1.6% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.38) EPS. Teladoc Health has set its Q3 2025 guidance at -0.350–0.200 EPS. FY 2025 guidance at -1.350–1.000 EPS. On average, equities research analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.